Cold virus weaponized to fight pancreatic cancer in early trial
Disease control
Completed
This early-stage trial tested the safety of a new treatment called LOAd703 for pancreatic cancer. LOAd703 is a modified common cold virus designed to infect and kill cancer cells while also boosting the body's immune system. The study involved 51 patients who received the virus a…
Phase: PHASE1, PHASE2 • Sponsor: Lokon Pharma AB • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC